United States
You have no items in your shopping cart.
AMPK
Inhibitory Selectivity
| Catalog No. | Inhibitor Name | AMPK |
|---|---|---|
| A13720 | Dorsomorphin 2HCl | ** |
| A14312 | WZ4003 | **** |
| A11970 | Dorsomorphin | ** |
| A16281 | HTH-01-015 | *** |
| A11071 | A 769662 | * |
| A15815 | ETC-1002 |
Notes:
1.Hover mouse over "" to view the IC50 value.(A few compounds have proven potency but without published IC50 data.)
2.For more details about the compound, click on the product name of your interest.
3.The higher the number of "" is, the more potent the inhibitor or activator is.
4."" refers to compounds which do inhibitory effects on the related isoform, but without specific value.
12 Item(s)
per page
| Catalog No. | Product Name | Application | Product Information |
|---|---|---|---|
A16284 |
YLF-466D |
AMPK activator |
YLF-466D is an allosteric AMPK activator.
|
A15896 |
GSK621 |
AMPK activator |
GSK621 is a potent and selective AMPK agonist.
|
A15815 SALE |
ETC-1002 |
ACL inhibitor and AMPK activator |
ETC-1002 is a novel, first-in-class, orally available, once-daily LDL-C lowering small molecule; activator of hepatic AMP-activated protein kinase (AMPK); also has potent inhibitory activity against hepatic ATP-citrate lyase(IC50=29 uM).
|
A10717 SALE |
Phenformin hydrochloride |
- |
Phenformin hydrochloride is a hydrochloride salt of phenformin from the biguanide drug class that displays anti-diabetic activity.
|
A14312 |
WZ4003 |
NUAK kinase inhibitor |
WZ4003 is a highly specific NUAK kinase inhibitor with IC50 of 20 nM and 100 nM for NUAK1 and NUAK2
|
A13720 SALE |
Dorsomorphin 2HCl |
BMP inhibitor |
Dorsomorphin, also known as BML-275, is a selective small molecule inhibitor of BMP signaling, which promotes cardiomyogenesis in embryonic stem cells. Dorsomorphin reverses the mesenchymal phenotype of breast cancer initiating cells by inhibition of bone morphogenetic protein signaling.
|
A11970 SALE |
BML-275 (Dorsomorphin) |
AMPK inhibitor |
BML-275 is a cell-permeable pyrazolopyrimidine compound shown to be an AMP-activated protein kinase (AMPK) and fatty acid synthase inhibitor.
|
A10028 SALE |
Acadesine (Aicar,NSC 105823) |
AMPK activator |
Acadesine is a selective activator of AMPK in both hepatocytes and adipocytes. |
A16281 |
HTH-01-015 |
NUAK1 inhibitor |
HTH-01-015 is a potent and selective inhibitor of NUAK1 (IC50 = 100 nM) and does not affect the activity of a panel of 139 other kinases, including additional AMPK family members.
|
A16282 |
Imeglimin |
oxidative phosphorylation blocker |
Imeglimin is an oxidative phosphorylation blocker that acts to inhibit hepatic gluconeogenesis, increase muscle glucose uptake, and restore normal insulin secretion.
|
A16283 |
Imeglimin hydrochloride |
oxidative phosphorylation blocker |
Imeglimin is the first in a new tetrahydrotriazine-containing class of oral antidiabetic agents, the glimins. It has been shown to act on the liver, muscle and pancreatic ??-cells to uniquely target the key defects of type 2 diabetes.
|
A11071 SALE |
A-769662 |
AMPK activator |
A-769662 is a new activator of AMP-activated protein kinase (AMPK).
|
12 Item(s)
per page
Adooq Guarantee
Guaranteed product quality
We promise all products perform as described.
